Medical News

---

• Neuropsychologic impairment largely present before psychosis onset
• Quitting cannabis may not alleviate psychosis
• Inhaled steroids may increase S. pneumoniae infection risk
• Serum heavy metal levels increased in lung disease patients
• Neuropsychologic impairment largely present before psychosis onset
• Quitting cannabis may not alleviate psychosis
• Cardiometabolic risk prevention opportunity in early schizophrenia
• GLP-1 pancreatitis concerns justified
• GLP-1 pancreatitis concerns justified
• Counting the cost of bariatric surgery
• Fatigue before cancer treatment impacts fatigue afterwards
• Cardiometabolic risk prevention opportunity in early schizophrenia
• Researchers bring hope for patients with aphasia

Neuropsychologic impairment largely present before psychosis onset Posted: 28 Feb 2013 04:00 PM PST Much of the cognitive impairment associated with psychosis is present before the full onset of symptoms, say researchers, although there are some progressive neuropsychologic impairments that occur in the transition to psychosis.

Quitting cannabis may not alleviate psychosis Posted: 28 Feb 2013 04:00 PM PST The amount of cannabis used does not appear to be associated with the severity of symptoms in patients with established psychosis, although the drug is linked to a small effect on psychosocial functioning, say UK scientists.

Inhaled steroids may increase S. pneumoniae infection risk Posted: 28 Feb 2013 04:00 PM PST Children with asthma who regularly use inhaled corticosteroids are at significantly increased risk for oropharyngeal colonization by Staphylococcus pneumonia, research suggests.

Serum heavy metal levels increased in lung disease patients Posted: 28 Feb 2013 04:00 PM PST Results from a large US study suggest that individuals with obstructive lung disease, particularly smokers, have significantly increased blood levels of cadmium and lead.

Neuropsychologic impairment largely present before psychosis onset Posted: 28 Feb 2013 04:00 PM PST Much of the cognitive impairment associated with psychosis is present before the full onset of symptoms, say researchers, although there are some progressive neuropsychologic impairments that occur in the transition to psychosis.

Quitting cannabis may not alleviate psychosis Posted: 28 Feb 2013 04:00 PM PST The amount of cannabis used does not appear to be associated with the severity of symptoms in patients with established psychosis, although the drug is linked to a small effect on psychosocial functioning, say UK scientists.

Cardiometabolic risk prevention opportunity in early schizophrenia Posted: 27 Feb 2013 04:00 PM PST Researchers have found that cardiometabolic risk in patients with schizophrenia is heightened in those with established disease, suggesting a need for early intervention in those presenting with their first episode.

GLP-1 pancreatitis concerns justified Posted: 27 Feb 2013 04:00 PM PST Study results have raised further concerns over a link between pancreatitis and the use of glucagon-like peptide-1 (GLP-1)-based therapies for patients with Type 2 diabetes.

GLP-1 pancreatitis concerns justified Posted: 27 Feb 2013 04:00 PM PST Study results have raised further concerns over a link between pancreatitis and the use of glucagon-like peptide-1 (GLP-1)-based therapies for patients with Type 2 diabetes.

Counting the cost of bariatric surgery Posted: 27 Feb 2013 04:00 PM PST Bariatric surgery for obese patients is not cost-saving relative to medical care, shows a 6-year follow-up study in JAMA Surgery.

Fatigue before cancer treatment impacts fatigue afterwards Posted: 27 Feb 2013 04:00 PM PST Individuals who survive cancer are significantly more likely to develop severe persistent fatigue a year after treatment if they were fatigued before and shortly after treatment, indicate Dutch study findings.

Cardiometabolic risk prevention opportunity in early schizophrenia Posted: 27 Feb 2013 04:00 PM PST Researchers have found that cardiometabolic risk in patients with schizophrenia is heightened in those with established disease, suggesting a need for early intervention in those presenting with their first episode.

Researchers bring hope for patients with aphasia Posted: 27 Feb 2013 04:00 PM PST Two groups of researchers have presented preliminary results of studies aiming to help in the treatment of aphasia at the conference of the American Association for the Advancement of Science in Boston, Massachusetts, USA, this month.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610